Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...

This article is brought to you by Ochsner Health. While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients.

FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...

Leronlimab demonstrated partial or complete responses in advanced metastatic colorectal cancer, supporting its potential in solid tumor oncology. Increased PD-L1 expression in triple-negative breast ...

Dr. Omer Awan, physician and public health expert, breaks down the latest data as well as health disparities associated with ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

From prevention to multidisciplinary management, up to options in the more advanced stages of the disease, these were the ...

The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...

Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...

Colorectal cancers have seen a 1% increase in deaths every year since 2005, while the mortality rate of every other type of ...